BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37626036)

  • 21. METTL3 facilitates tumor progression via an m
    Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
    Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. lncARSR sponges miR-34a-5p to promote colorectal cancer invasion and metastasis via hexokinase-1-mediated glycolysis.
    Li S; Zhu K; Liu L; Gu J; Niu H; Guo J
    Cancer Sci; 2020 Oct; 111(10):3938-3952. PubMed ID: 32798250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
    Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
    Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/β-catenin pathway.
    Duan L; Wu R; Ye L; Wang H; Yang X; Zhang Y; Chen X; Zuo G; Zhang Y; Weng Y; Luo J; Tang M; Shi Q; He T; Zhou L
    PLoS One; 2013; 8(4):e62092. PubMed ID: 23637971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A feedback circuit comprising EHD1 and 14-3-3ζ sustains β-catenin/c-Myc-mediated aerobic glycolysis and proliferation in non-small cell lung cancer.
    Huang J; Tian F; Song Y; Cao M; Yan S; Lan X; Cui Y; Cui Y; Cui Y; Jia D; Cai L; Xing Y; Wang X
    Cancer Lett; 2021 Nov; 520():12-25. PubMed ID: 34217785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Moesin (MSN) as a Potential Therapeutic Target for Colorectal Cancer via the β-Catenin-RUNX2 Axis.
    Huang CY; Wei PL; Batzorig U; Makondi PT; Lee CC; Chang YJ
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA LEF1-AS1/LEF1/FUT8 Axis Mediates Colorectal Cancer Progression by Regulating α1, 6-Fucosylationvia Wnt/β-Catenin Pathway.
    Qi Y; Shan Y; Li S; Huang Y; Guo Y; Huang T; Zhao X; Jia L
    Dig Dis Sci; 2022 Jun; 67(6):2182-2194. PubMed ID: 34021424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway.
    Yu J; Han Z; Sun Z; Wang Y; Zheng M; Song C
    J Exp Clin Cancer Res; 2018 Sep; 37(1):222. PubMed ID: 30201010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circ-IGF1R Affects the Progression of Colorectal Cancer by Activating the miR-362-5p/HMGB3-Mediated Wnt/β-Catenin Signal Pathway.
    Gao S; Zhang X; Bai W; Wang J; Jiang B
    Biochem Genet; 2023 Jun; 61(3):1210-1229. PubMed ID: 36542208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The microRNA-381(miR-381)/Spindlin1(SPIN1) axis contributes to cell proliferation and invasion of colorectal cancer cells by regulating the Wnt/β-catenin pathway.
    Zhou L; Wang H; Fang Z; Zhong M; He Y; Zou J; Huang S; Li J; Xiang X; Fang Z
    Bioengineered; 2021 Dec; 12(2):12036-12048. PubMed ID: 34753384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circ_0082182 promotes oncogenesis and metastasis of colorectal cancer in vitro and in vivo by sponging miR-411 and miR-1205 to activate the Wnt/β-catenin pathway.
    Liu R; Deng P; Zhang Y; Wang Y; Peng C
    World J Surg Oncol; 2021 Feb; 19(1):51. PubMed ID: 33596920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β-catenin signaling axis.
    Jiang S; Miao D; Wang M; Lv J; Wang Y; Tong J
    J Cell Mol Med; 2019 Jan; 23(1):630-640. PubMed ID: 30338942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wnt signaling modulator DKK4 inhibits colorectal cancer metastasis through an AKT/Wnt/β-catenin negative feedback pathway.
    Liang J; Sun L; Li Y; Liu W; Li D; Chen P; Wang X; Hui J; Zhou J; Liu H; Cao T; Pang M; Guo M; Wang X; Zhao X; Lu Y
    J Biol Chem; 2022 Nov; 298(11):102545. PubMed ID: 36181792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis.
    Jiang Y; Han Q; Zhao H; Zhang J
    J Exp Clin Cancer Res; 2021 Jan; 40(1):13. PubMed ID: 33407720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N
    Li Y; He L; Wang Y; Tan Y; Zhang F
    Bioengineered; 2022 May; 13(5):11923-11932. PubMed ID: 35546050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MNX1 promotes cell proliferation and activates Wnt/β-catenin signaling in colorectal cancer.
    Yang X; Pan Q; Lu Y; Jiang X; Zhang S; Wu J
    Cell Biol Int; 2019 Apr; 43(4):402-408. PubMed ID: 30614606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression.
    Wei W; Zhang ZY; Shi B; Cai Y; Zhang HS; Sun CL; Fei YF; Zhong W; Zhang S; Wang C; He B; Jiang GM; Wang H
    J Exp Clin Cancer Res; 2023 Jun; 42(1):151. PubMed ID: 37340443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5.
    Zhang M; Weng W; Zhang Q; Wu Y; Ni S; Tan C; Xu M; Sun H; Liu C; Wei P; Du X
    J Hematol Oncol; 2018 Sep; 11(1):113. PubMed ID: 30185232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Favorable prognosis in colorectal cancer patients with co-expression of c-MYC and ß-catenin.
    Lee KS; Kwak Y; Nam KH; Kim DW; Kang SB; Choe G; Kim WH; Lee HS
    BMC Cancer; 2016 Sep; 16(1):730. PubMed ID: 27619912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The metastasis suppressor, NDRG1, inhibits "stemness" of colorectal cancer via down-regulation of nuclear β-catenin and CD44.
    Wangpu X; Yang X; Zhao J; Lu J; Guan S; Lu J; Kovacevic Z; Liu W; Mi L; Jin R; Sun J; Yue F; Ma J; Lu A; Richardson DR; Wang L; Zheng M
    Oncotarget; 2015 Oct; 6(32):33893-911. PubMed ID: 26418878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.